ASA upholds Black Friday Mounjaro ad complaints
What happened
The ASA upheld two complaints against online weight-loss providers for Black Friday 2025 advertising. Juniper ran Instagram ads promoting Mounjaro with time-limited Black Friday discounts. Voy sent email promotions for Wegovy and tirzepatide with countdown urgency. Both breached CAP Code rules 12.12 (POM advertising ban) and 1.3 (social responsibility).
This is significant because the ASA applied both rules together — the POM ban and the social responsibility requirement — creating a double violation that makes the ruling harder to dismiss as a technicality.
Who this affects
- Online pharmacies and weight-loss clinics using seasonal promotions or discount campaigns for GLP-1 medicines
- Marketing teams planning "sales events" around regulated prescription medicines
- Agencies managing paid social and email campaigns for healthcare clients
What it means
The "double breach" pattern matters. Even if you avoid naming the POM directly, creating urgency around weight-loss treatment availability or pricing can still breach social responsibility rules. The ASA is looking at the overall pressure tactics, not just whether the drug name appears.
What to watch next
With the ASA's AI monitoring system now live, similar seasonal promotions will likely be caught automatically. Expect pre-Christmas and New Year enforcement sweeps targeting weight-loss ads.